233,95 €
233,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
117 °P sammeln
233,95 €
233,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
117 °P sammeln
Als Download kaufen
233,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
117 °P sammeln
Jetzt verschenken
233,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
117 °P sammeln
  • Format: PDF

This volume of Advances in Neurobiology deals with the Neurochemistry of disease, with chapters covering both human diseases and animal "model" disorders. Specific diseases are covered in chapters on neurodegenerations such as Alzheimer's and Parkinson's, on demyelinating diseases, on autism, and so on. This volume on Neurochemical Mechanisms in Disease strives to encourage more chemically based definitions of these and other diseases.

  • Geräte: PC
  • ohne Kopierschutz
  • eBook Hilfe
  • Größe: 13.31MB
Produktbeschreibung
This volume of Advances in Neurobiology deals with the Neurochemistry of disease, with chapters covering both human diseases and animal "model" disorders. Specific diseases are covered in chapters on neurodegenerations such as Alzheimer's and Parkinson's, on demyelinating diseases, on autism, and so on. This volume on Neurochemical Mechanisms in Disease strives to encourage more chemically based definitions of these and other diseases.

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
John P Blass, MD, PhD, has been studying the chemistry of diseases of the brain for over half a century: as an undergraduate at Harvard, as a graduate student with Henry McIlwain, as a postdoctoral fellow first with Heinrich Waelsch and then with Daniel Steinberg, during eight years at the Mental Retardation Center at UCLA, and since 1978 as Burke Professor of Neurology, Neuroscience, and Medicine at Weill Cornell Medical College in New York City (now professor emeritus). His work has concentrated on the role of reductions in brain metabolism in Alzheimer's disease and other disorders impairing cognition.